Sargramostim for Prophylactic Management of Gastrointestinal Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy for Cancer

by Michael Dougan, Long H. Nguyen, Elizabeth I. Buchbinder, Hillard M. Lazarus
Published 2024-01-01

Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?

by Hillard M. Lazarus, Carolyn E. Ragsdale, Robert Peter Gale, Gary H. Lyman
Published 2021-08-01

Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas

by Ibrahim N. Muhsen, Riad El Fakih, Mehdi Hamadani, Hillard M. Lazarus, Mohamed A. Kharfan-Dabaja, Mahmoud Aljurf
Published 2022-06-01

Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature revi...

by Stephen Jolles, Sergio Giralt, Tessa Kerre, Hillard M. Lazarus, S. Shahzad Mustafa, S. Shahzad Mustafa, Roberto Ria, Donald C. Vinh
Published 2023-02-01

Possible Role of Correlation Coefficients and Network Analysis of Multiple Intracellular Proteins in Blood Cells of Patients with Bipolar Disorder in Studying the Mechanism of Lith...

by Keming Gao, Marzieh Ayati, Nicholas M. Kaye, Mehmet Koyuturk, Joseph R. Calabrese, Eric Christian, Hillard M. Lazarus, David Kaplan
Published 2024-03-01

Divergent Directionality of Immune Cell-Specific Protein Expression between Bipolar Lithium Responders and Non-Responders Revealed by Enhanced Flow Cytometry

by Keming Gao, Nicholas M. Kaye, Marzieh Ayati, Mehmet Koyuturk, Joseph R. Calabrese, Eric Christian, Hillard M. Lazarus, David Kaplan
Published 2023-01-01

Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes

by Maya Breitman, Tracey L. Bonfield, Arnold I. Caplan, Hillard M. Lazarus, Maricela Haghiac, Susan LaSalvia, Jane Reese‐Koc, Nora G. Singer
Published 2022-02-01

Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the “First in Cystic Fibrosis” Phase I Clinical Trial (CEASE-CF)

by Tracey L. Bonfield, Morgan T. Sutton, David R. Fletcher, Jane Reese-Koc, Erica A. Roesch, Hillard M. Lazarus, James F. Chmiel, Arnold I. Caplan
Published 2023-02-01

Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia

by Masumi Ueda, Masumi Ueda, Tammy Stefan, Lindsay Stetson, James J. Ignatz-Hoover, Benjamin Tomlinson, Benjamin Tomlinson, Richard J. Creger, Richard J. Creger, Brenda Cooper, Brenda Cooper, Hillard M. Lazarus, Hillard M. Lazarus, Marcos de Lima, Marcos de Lima, David N. Wald, David N. Wald, Paolo F. Caimi, Paolo F. Caimi
Published 2020-03-01

Real‐world outcomes of 18,186 metastatic solid tumor outpatients: Baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapy

by Jerome H. Goldschmidt, Lin‐Na Chou, Philip K. Chan, Liwei Chen, Nicholas Robert, Joyce Kinsey, Katherine Pitts, Matt Nestor, Edwin P. Rock, Hillard M. Lazarus
Published 2023-11-01

Notch2 blockade enhances hematopoietic stem cell mobilization and homing

by Weihuan Wang, Shuiliang Yu, Jay Myers, Yiwei Wang, William W. Xin, Marwah Albakri, Alison W. Xin, Ming Li, Alex Y. Huang, Wei Xin, Christian W. Siebel, Hillard M. Lazarus, Lan Zhou
Published 2017-10-01

Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment

by Morgan T. Sutton, David Fletcher, Santosh K. Ghosh, Aaron Weinberg, Rolf van Heeckeren, Sukhmani Kaur, Zhina Sadeghi, Adonis Hijaz, Jane Reese, Hillard M. Lazarus, Donald P. Lennon, Arnold I. Caplan, Tracey L. Bonfield
Published 2016-01-01

Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model

by Leland Metheny, Saada Eid, Saada Eid, Karen Lingas, Karen Lingas, Racheli Ofir, Lena Pinzur, Howard Meyerson, Howard Meyerson, Hillard M. Lazarus, Alex Y. Huang, Alex Y. Huang, Alex Y. Huang, Alex Y. Huang
Published 2018-02-01

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders

by Hillard M. Lazarus, Katherine Pitts, Tisha Wang, Elinor Lee, Elizabeth Buchbinder, Elizabeth Buchbinder, Elizabeth Buchbinder, Michael Dougan, Michael Dougan, Michael Dougan, David G. Armstrong, Robert Paine, Carolyn E. Ragsdale, Timothy Boyd, Edwin P. Rock, Robert Peter Gale
Published 2023-01-01

Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors

by David I. Marks, Kwang Ahn Woo, Xiaobo Zhong, Frederick R. Appelbaum, Veronika Bachanova, Juliet N. Barker, Claudio G. Brunstein, John Gibson, Partow Kebriaei, Hillard M. Lazarus, Richard Olsson, Miguel-Angel Perales, Joseph Pidala, Bipin Savani, Vanderson Rocha, Mary Eapen
Published 2014-02-01

Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900

by Hugo F. Fernandez, Zhuoxin Sun, Mark R. Litzow, Selina M. Luger, Elisabeth Paietta, Janis Racevskis, Ross L. Levine, Jay P. Patel, Omar Abdel-Wahab, Rhett P. Ketterling, Gordon W. Dewald, John M. Bennett, Jacob M. Rowe, Hillard M. Lazarus, Martin S. Tallman
Published 2019-04-01

The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes

by Andrew S. Artz, Brent Logan, Xiaochun Zhu, Gorgun Akpek, Rodrigo Martino Bufarull, Vikas Gupta, Hillard M. Lazarus, Mark Litzow, Alison Loren, Navneet S. Majhail, Richard T. Maziarz, Philip McCarthy, Uday Popat, Wael Saber, Stephen Spellman, Olle Ringden, Amittha Wickrema, Marcelo C. Pasquini, Kenneth R. Cooke
Published 2016-11-01

Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for Inte...

by Armand Keating, Gisela DaSilva, Waleska S. Pérez, Vikas Gupta, Corey S. Cutler, Karen K. Ballen, Mitchell S. Cairo, Bruce M. Camitta, Richard E. Champlin, James L. Gajewski, Hillard M. Lazarus, Michael Lill, David I. Marks, Chadi Nabhan, Gary J. Schiller, Gerald Socie, Jeffrey Szer, Martin S. Tallman, Daniel J. Weisdorf
Published 2013-02-01

The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial

by David I. Marks, Anthony V. Moorman, Lucy Chilton, Elisabeth Paietta, Amir Enshaie, Gordon DeWald, Christine J. Harrison, Adele K. Fielding, Letizia Foroni, Anthony H. Goldstone, Mark R. Litzow, Selina M. Luger, Andrew K. McMillan, Janis Racevskis, Jacob M. Rowe, Martin S. Tallman, Peter Wiernik, Hillard M. Lazarus
Published 2013-06-01

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

by Bhagirathbhai Dholaria, Bipin N. Savani, Myriam Labopin, Leo Luznik, Annalisa Ruggeri, Stephan Mielke, Monzr M. Al Malki, Piyanuch Kongtim, Ephraim Fuchs, Xiao-Jun Huang, Franco Locatelli, Franco Aversa, Luca Castagna, Andrea Bacigalupo, Massimo Martelli, Didier Blaise, Patrick Ben Soussan, Yolande Arnault, Rupert Handgretinger, Denis-Claude Roy, Paul O’Donnell, Asad Bashey, Scott Solomon, Rizwan Romee, Philippe Lewalle, Jorge Gayoso, Michael Maschan, Hillard M. Lazarus, Karen Ballen, Sebastian Giebel, Frederic Baron, Fabio Ciceri, Jordi Esteve, Norbert-Claude Gorin, Alexandros Spyridonidis, Christoph Schmid, Stefan O. Ciurea, Arnon Nagler, Mohamad Mohty
Published 2020-01-01